• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Glioblastoma Drug Pipeline Capsule - 2012 Update Product Image

Global Glioblastoma Drug Pipeline Capsule - 2012 Update

  • ID: 2234461
  • September 2012
  • Region: Global
  • 18 pages
  • Fore Pharma

Fore Pharma's latest report 'Global Glioblastoma Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Glioblastoma market. It covers active Glioblastoma pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Features of the Report:
- Glioblastoma: Overview
- Glioblastoma Pipeline Overview
- Glioblastoma Phase 3 Clinical Trial Pipeline Insights
- Glioblastoma Phase 2 Clinical Trial Pipeline Insights
- Glioblastoma Phase 1 Clinical Trial Pipeline Insights
- Glioblastoma Preclinical Research Pipeline Insights
- Glioblastoma Discovery Stage Pipeline Insights
- Geographic Landscape of Glioblastoma R&D Activities
- Glioblastoma R&D Activities in North America
- Glioblastoma R&D Activities in Europe
- Licensing Activities / Partnerships

1. Glioblastoma - Disease Overview
2. Glioblastoma Pipeline Overview
3. Glioblastoma Phase 3 Clinical Trial Pipeline Insights
4. Glioblastoma Phase 2 Clinical Trial Pipeline Insights
5. Glioblastoma Phase 1 Clinical Trial Pipeline Insights
6. Glioblastoma Preclinical Research Pipeline Insights
7. Glioblastoma Discovery Stage Pipeline Insights
8. Glioblastoma Drug Development Activities - Geographic Landscape
8.1. Glioblastoma R&D Activities in North America
8.2. Glioblastoma R&D Activities in Europe
9. Glioblastoma Pipeline - Licensing Activities
Table 1. Glioblastoma Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Glioblastoma Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Glioblastoma Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Glioblastoma Pipeline Molecules - Preclinical Research
Table 5. Glioblastoma Pipeline Molecules - Drug Discovery
Table 6. Glioblastoma R&D Activities by Geography
Table 7. Glioblastoma Pipeline Molecules - North America
Table 8. Glioblastoma Pipeline Molecules - Europe
Table 9. Glioblastoma Pipeline - Licensing Activities

Figure 1. Glioblastoma Pipeline Molecules by R&D Stage
Figure 2. Glioblastoma R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos